To compare the effects of sub-anaesthetic concentrations of propofol and halothane on the respiratory control system, we have studied the acute ventilatory response to isocapnic hypoxia (AHVR) in 12 adults with and without three different concentrations of propofol and halothane. Target doses for propofol were 0, 0.05, 0.1 and 0.2 of the effective plasma concentration (EC50 ϭ 8.1 g ml
was held constant at 0.13-0.27 kPa greater than the subject's natural level throughout. The mean values for AHVR with propofol were: 12. More than 15 yr ago Knill and Gelb showed that a sub-anaesthetic dose of halothane (0.1 MAC) suppressed the ventilatory response to hypoxia in humans [1] . The possibility of a direct anaesthetic action on the carotid body chemoreceptors was proposed [2, 3] . Knill and colleagues subsequently reported that enflurane and isoflurane had similar actions [4, 5] . These findings have been confirmed for 0.1 % inspired halothane [6] , 0.1 MAC and 0.15 MAC of halothane [7, 8] , and 0.1 MAC of enflurane [9] . Less is known about the effect of sedative doses of i.v. anaesthetics on the hypoxic ventilatory response in adults. Blouin and colleagues showed that sedation with a propofol infusion is associated with profound depression of the hypoxic ventilatory response measured during hypercapnia ( ′ 2 CO E P was 0.81 kPa greater than the subject's natural value) [10] . On the other hand, two separate studies of patients sedated with propofol during spinal anaesthesia concluded that sub-anaesthetic doses of propofol had no respiratory depressant effect [11, 12] .
Because of the increasing and widespread use of propofol sedation, we designed our study to compare the effects of low concentrations of propofol on the hypoxic ventilatory response with that of halothane at similar levels of sedation in the same subjects.
Subjects and methods
The study was approved by the Central Oxford Research Ethics Committee. Twelve healthy adult volunteers (nine males) were recruited. They were non-smokers with a mean age of 21.1 (range 18-28) yr, height 1.83 (1.72-1.93) m and weight 75.6 (60-92) kg. After giving informed consent they were familiarized with the experimental procedure and apparatus. Before each session, all were asked to refrain from food and drink for at least 6 h. To minimize differences in the level of consciousness, subjects were asked to watch television.
Before the propofol studies an 18-gauge i.v. cannula was inserted in a forearm vein under local anaesthesia for infusion of propofol, and a 16-gauge cannula was sited similarly in a forearm vein of the contralateral limb for sampling of venous blood. A pulse oximeter (Ohmeda Biox 3740, finger probe) was used to monitor arterial oxygen saturation and heart rate throughout.
To was held constant at 0.13-0.27 kPa greater than the subject's natural level throughout.
Subjects breathed through a mouthpiece with the nose occluded. Respiratory volumes were recorded using a turbine volume measuring device [13] and flows were recorded using a pneumotachograph in series. Respired gas at the mouth was analysed for PO2 , PCO2 (and halothane) using a mass spectrometer. All ventilatory variables were recorded on an IBM PC AT computer, which determined for each breath the inspiratory and expiratory durations, inspiratory and expiratory volumes, and end-tidal gas composition for carbon dioxide and oxygen. Breath-bybreath values for P ′ were passed to a second computer which compared these actual values with the desired values, and adjusted the composition of the inspired gas to maintain the desired end-tidal values independently of changes in ventilation. Details of the dynamic end-tidal forcing technique and gas-mixing system are described in more detail elsewhere [14, 15] .
PROPOFOL EXPERIMENTS
The propofol administration regimen, including target and actual values measured in plasma for propofol, is shown in table 1. The target levels of sedation with propofol were chosen to be similar to the target levels of sedation with halothane, by taking the effective plasma concentration of propofol (EC50 ϭ 8.1 g ml
Ϫ1
) [16] to be equivalent to 1 MAC of halothane (0.77 %) [17] . During each experimental period, the infusion rate was high for the first 1 min to provide a loading dose of propofol. The infusion rate was then reduced to a maintenance dose for the remaining 19 min. The infusion regimen was designed to provide steady plasma concentrations of 0, 0.05, 0.1 and 0.2 of the EC50 using the pharmacokinetic model of Gepts and colleagues [18] . There was a 30-45-min interval between experimental periods, during which subjects breathed room air, to allow for elimination of propofol from body stores. It was recognized that some accumulation of propofol was to be expected despite the presence of these intervals. Control of Blood samples for propofol concentrations were obtained immediately before and at 10 and 20 min into each experimental period. They were stored in heparinized tubes for analysis by high performance liquid chromatography (HPLC; Perkin Elmer Series 2 Liquid Chromatograph, Norwalk, CT, USA). We used a modified form of the method described by Adam and colleagues [19] (see appendix). Each of the 12 volunteers was studied with and without three different doses of propofol on the same day in random order.
HALOTHANE EXPERIMENTS
Halothane was administered using a Dräger vaporizer (Drägerwerk, Lübeck). A mass spectrometer (Airspec 3000, Airspec Ltd, Biggin Hill, Kent) was used for detection of inspired and expired halothane concentrations and was calibrated using a standard gas mixture of 0.208 % halothane in air (British Oxygen Company, London; halothane concentration certified to be within the range 0.198-0.218 %). The mass number used for halothane was 117. The inspired concentration was adjusted manually to maintain an end-tidal concentration constant at one of the target values: 0, 0.05, 0.1 and 0.2 MAC. The dose-response relationship is presented as a function of end-expired halothane concentration expressed in units of MAC. Each of the 12 subjects was studied with and without three different doses of halothane on the same day in random order. There were 30-min breaks between the experimental periods.
DATA ANALYSIS
Data from each experimental period were averaged over 60-s intervals. For each subject mean values for resting ventilation during the last 1 min of normoxia before the step change into hypoxia (baseline ventilation or normoxic ventilation, VEA) and for the third min after the step (VEB) were analysed further. The acute hypoxic ventilatory response (AHVR) was calculated as the difference between VEB and VEA for each concentration of propofol or halothane. The statistical significance of the results was assessed by analysis of variance using a linear model. Using the notation of Armitage and Berry [20] , the particular model used may be written as:
where ϭ overall mean, S ϭ the subject (a random factor), D ϭ the drug (either halothane or propofol, a factor taking only two values), C ϭ concentration of the drug (in MAC or EC50, a covariate), and e ϭ an error term. The significance of the terms was assessed using F ratio tests, with P Ͻ 0.05 considered significant. Analysis was performed using MS DOS on a Dell 320 LX PC with Minitab release 7 statistical software.
Results
With 0.05 and 0.1 MAC of halothane, all subjects were sedated only lightly, co-operative and without amnesia for the experimental period. At 0.2 MAC of halothane, sedation was more intense and one of our subjects was unable to finish the experiment because of excitation, nausea and discomfort. Using propofol we observed levels of sedation similar to those with halothane. A few subjects reported arm discomfort during the first few minutes of administration of propofol. Mean blood concentrations of propofol are given in table 1 and mean values for inspired and end-tidal halothane concentrations are given in table 2. Figure 1 illustrates the ventilatory responses and end-tidal gas profiles for the four different plasma concentrations of propofol in one subject (938). Figure 2 illustrates the responses for four different concentrations of halothane in one subject (965). On the whole the responses to hypoxia were smaller during propofol and halothane sedation than during control (no drug administration). the 12 subjects are shown in table 4. Figure 3 shows the mean AHVR dose-response curves. There was a statistically significant decline in AHVR with both drugs (F ϭ 49.96, P Ͻ 0.001); however, there was no significant difference between the two drugs in this decrease (F ϭ 2.36, ns). The difference between the slopes of the dose-response curves was 15. figure 4 . There was a small but significant decrease in normoxic ventilation with increasing dose of drug (F ϭ 30.03, P Ͻ 0.001). There appeared to be some differences between halothane and propofol (F ϭ 4.62, P Ͻ 0.05). As the response curves did hot appear entirely linear, it may be that the particular statistical model used was too simple. However, it was not felt that there were data for a sufficiently large, number of different concentrations to justify further analysis. Figure 3 Dose-response curves (mean, SEM) for the acute hypoxic ventilatory response (AHVR) for all 12 subjects with halothane (Hal.) ( ) and propofol (P) ( ) sedation. The increase in ventilation at the onset of hypoxia (AHVR) is plotted as a function of MAC (halothane) or EC50 (propofol). [6] . However, study methods differed. Knill and Gelb introduced hypoxia gradually over a period of 8-10 min [1] . In our study and those of Young, Drummond and Warren [6] and Dahan and colleagues [8] , hypoxia was introduced abruptly as a step change. A second difference between the studies is that Young, Drummond and Warren [6] selected only subjects who responded to hypoxia by increasing their ventilation by 20 % or more during the first visit to the laboratory. A third difference relates to the precision of control exercised over the endtidal gases. For example, Young, Drummond and Warren [6] did not avoid a degree of hypocapnia at the start of hypoxia in the control study. Finally, in some subjects a mild degree of hypercapnia was used whereas with other studies this was not the case. These factors may account for some of the differences between these studies.
ACUTE HYPOXIC VENTILATORY RESPONSE WITH PROPOFOL SEDATION. COMPARISON WITH OTHER

STUDIES
The results presented here demonstrated that low plasma concentrations of propofol depressed AHVR in a dose-dependent manner. One other study described the ventilatory response to hypoxia during a low-dose propofol infusion which achieved a plasma concentration of 2.2 g ml Ϫ1 (0.27 EC50); this study by Blouin and colleagues [10] was conducted under steady hypercapnia.
The mean age of our subjects was substantially lower than that of the study of Davidson and colleagues (48.4 yr) [16] from which we obtained an EC50 value for propofol. However, the value of MAC obtained for halothane pertains to a mean age of 42 yr [17] which is close to that of the subjects of Davidson and colleagues [16] . If we assume that both EC50 and MAC are affected similarly by age, then our use of values for subjects in their fifth decade should introduce no systematic error in our comparison of the effects of propofol and halothane in younger subjects.
NORMOXIC VENTILATION WITH HALOTHANE AND PROPOFOL SEDATION. COMPARISON WITH OTHER
STUDIES
Knill and Gelb found no difference in baseline ventilation at 0.1 MAC of halothane [1] . Similarly, Young, Drummond and Warren [6] concluded that 0.1 MAC of halothane had no significant effect on normoxic ventilation, and Dahan and colleagues [8] found no effect of 0.15 MAC of halothane. In contrast with these studies, we found a small but significant reduction in normoxic ventilation with increasing dose of halothane. For propofol, Blouin and colleagues [10] observed a reduction in baseline ventilation of 45 % using a dose of 0.27 EC50. This is broadly in keeping with the current study, where a 37 % decrease in normoxic ventilation was observed using a dose of 0.26 EC50.
LEVEL OF STIMULATION AND CONSCIOUSNESS OF
SUBJECTS
Attention has been drawn to the importance of the level of stimulation of subjects in determining their ventilatory responses. Shea and colleagues [21] showed that adding audiovisual input to baseline conditions of rest and low sensory input increased resting VE. In sedated subjects, van den Elsen and colleagues [22] observed a large difference in AHVR with and without audiovisual stimulation, even though the same dose of isoflurane was used in both circumstances. This subject has been reviewed recently by Robotham [23] .
In our study, we asked subjects to remain attentive and watch television. At the lower doses, below 0.15 MAC/EC50, subjects were successful in achieving this. These findings would seem to be in accord with the study of Knill and Gelb [1] whose subjects at 0.1 MAC of halothane were well-oriented with full recollection of the study afterwards. At the maximal doses in our study, there was a substantial incidence of eye closure and loss of attention. In their study of 0.05 and 0.1 MAC of halothane, Dahan and colleagues [7] excluded experiments in which subjects failed to open their eyes in response to calling their name. In contrast, during their study of 0.15 MAC of halothane, Dahan and colleagues [8] only included subjects who had lost consciousness as judged by several criteria. In their study of subanaesthetic infusions of propofol, Blouin and colleagues [10] adopted a different approach, and titrated the dose of propofol against the subject's level of consciousness. They chose a dose to maintain a level of somnolence at which subjects exhibited spontaneous eye closure and slurred speech, yet responded to verbal stimuli. This dose corresponded very closely to the highest dose of propofol used in our study.
CLINICAL IMPLICATIONS
The question of whether the depressant effect of anaesthetic agents in low doses on the AHVR is clinically important remains controversial. Robotham [23] argues that "a patient may be at risk with a depressed ventilatory response to hypoxia with even 0.1 MAC halothane, enflurane, or isoflurane." Goodman [24] has suggested that "for most patients complete loss of the hypoxic response does not matter." He emphasized the hazard of airway obstruction claiming that "the risk to all patients during recovery from anaesthesia is from obstruction of the airway, not from the ventilatory depression". We have two comments to make. First, an important component of the defence to airway obstruction is arousal and this is likely to be mediated, at least in part, by a peripheral chemoreflex response to hypoxia. Second, postoperative hypoxaemia may result from factors other than airway obstruction and a ventilatory response may help to alleviate this.
